Health and Healthcare

Health and Healthcare Articles

That experiencing a decline in income might upset somebody is a no-brainer, but new research suggests that it might literally affect the brain in negative ways.
On days when the main stock market indexes are trading sharply lower, it is interesting to see what stocks and sectors are up on the day.
One analyst issued a fairly bullish report in response to Johnson & Johnson's announcement of a $10 million settlement with two Ohio counties ahead of an upcoming opioid trial.
Merck has just announced that the FDA has accepted a couple new drug applications for review, including for a treatment for Clostridium difficile infections in children.
These three biotech stocks have upcoming clinical data and presentations that could be huge, and they could blast the stocks higher.
Conformis shares shot up on Tuesday after the firm announced that it has entered into definitive agreements to sell and license to Stryker to develop, manufacture and supply PSI for use in connection...
Five drugmakers are considering a proposal that would have them contribute to a trust established as part of the bankruptcy settlement by Purdue Pharmaceuticals and be released from liability in the...
Minerva Neurosciences shares dropped sharply on Tuesday after the firm announced that it was the victim of a cyberattack. Minerva also provided an update on its clinical trials.
Catabasis Pharma shares jumped early on Tuesday after the firm announced that it had completed the enrollment for its late-stage Duchenne muscular dystrophy (DMD) study. Specifically, the enrollment...
New research shows that for those afflicted with type 2 diabetes, losing even 15 or 20 pounds can send the disease into remission. Some 400 million people worldwide have type 2 diabetes, a condition...
Immunomedics shares dropped sharply on Monday after the firm presented interim data from its midstage bladder cancer study at the European Society for Medical Oncology (ESMO) Annual Congress in...
ImmunoGen shares dropped on Monday after the firm released data from its late-stage ovarian cancer study at the European Society for Medical Oncology (ESMO) 2019 Congress in Barcelona, Spain.
Dova Pharmaceuticals shares jumped on Monday after the firm announced that it would be acquired by Swedish Orphan Biovitrum, or Sobi. But are Dova investors getting enough out of this acquisition?
These four top large-cap pharmaceutical stocks for investors to consider all pay solid dividends and look like very solid fourth-quarter ideas.
Pfizer has announced positive top-line results from a second Phase 3 pivotal study evaluating abrocitinib, in patients aged 12 and older with moderate to severe atopic dermatitis.
AI Portfolio

Discover Our Top AI Stocks

Our expert who first called NVIDIA in 2009 is predicting 2025 will see a historic AI breakthrough.

You can follow him investing $500,000 of his own money on our top AI stocks for free.